Key Insights Fatigue is a common but usually temporary side effect during the initial weeks or dose changes in GLP-1 therapy, caused largely by rapid calorie deficit, dehydration, and metabolic adjustments. Maintaining steady energy requires prioritising nutrient-dense meals rich in protein and complex carbohydrates, staying well hydrated, and managing electrolyte balance, which helps mitigate tiredness and supports overall metabolism. Gentle physical activity and good sleep hygiene are critical lifestyle adjustments that improve circulation, mood, and energy levels without overtaxing the body during the drug adaptation period. Persistent, worsening, or debilitating fatigue should prompt medical evaluation to exclude other causes, reassess medication dosing, and ensure safe continuation of GLP-1 therapy under healthcare supervision. Frequently asked questions Why do GLP-1 medications cause fatigue
That being said, our medical professionals at our clinic prescribe Semaglutide in a manner that is unique to each patient
Future BPC-157 Research BPC-157 is under active investigation in a number of cell culture and animal models
The insurer cited the same cost sustainability concerns that drove BCBS decisions, adding that member premium stability required difficult choices about which therapies the plan could continue to support at current pricing levels
Enjoy early accessgrab our Free Peptide 101 Guide and unlock 25% off your first order
